Researchers have been excited about the medication , a groundbreaking dual agonist showing remarkable outcomes in clinical trials for body loss . It acts by impacting several hormones : GLP-1 and GIP, that , when engaged , assist influence hunger and boost metabolism . Preliminary observations indicate noteworthy weight management and possible impr